期刊文献+

一家大型医院住院患者骨质疏松症诊治现状的初步调查 被引量:15

A preliminary investigation of diagnosis and treatment on osteoporosis among inpatients in a large hospital
下载PDF
导出
摘要 目的调查四川大学华西医院的住院患者,以了解目前我国大型医院住院患者中骨质疏松症的诊治现状。方法采用自行设计的骨质疏松症调查问卷,通过事前培训的调查人员于同一日对四川大学华西医院住院患者进行问卷调查。由长期从事骨质疏松症临床研究工作的高级专业人员对问卷信息进行分析汇总。使用SPSS 13.0统计软件对所得数据进行统计学分析。结果本次共调查2059例住院患者,占该院当日住院患者总数的47.9%。其中骨质疏松症高危患者1186例,占被调查患者的57.6%。骨质疏松症高危患者比例较高的科室分别为老年科(97.3%),其次为疼痛科(82.1%)、风湿免疫科(77%)、内分泌科(71.6%)。这些高危患者已行DXA骨密度检测者171人,占14.4%,检测比例较高的科室分别为老年科(29.8%),康复科(28.9%)和内分泌科(28.6%)。骨质疏松症高危患者中有584人(49.2%)正在使用钙剂,其中正在进行抗骨质疏松药物治疗者43人,占存在治疗意愿患者的7.4%(43/584),占骨质疏松症高危患者的3.6%(43/1186)。抗骨质疏松药物治疗比例相对较高的科室分别为内分泌科(12.7%)、康复科(8.9%)、风湿免疫科(8.8%)。结论综合性大型医院住院患者中,骨质疏松症高危患者比例较高,但其中得到及时诊治的患者比例较低。骨质疏松症高危患者多自行采用钙剂,目前的临床医疗服务远未满足患者的需求。 Objective To investigate the current status of diagnosis and treatment on osteoporosis in West China Hospital of Sichuan University among inpatients by osteoporosis questionnaires. Methods The self-designed question- naire was conducted to West China Hospital of Sichuan University inpatients in a given day by pre-training survey of of_ ricers. The total information was analyzed by the senior professionals who were engaged in clinical study of osteoporosis for a long-term. The data were dealt with SPSS13.0 statistical software. Results Totally 2059 inpatients (47.9% of the whole inpatients) were investigated. Among these patients, 1186 (57. 6% ) were at high risk for osteoporosis. Depart- ment of geriatrics has the highest proportion of patients who were at high risk for osteoporosis (97. 3% ), followed by de- partments of pain management (82. 1% ), rheumatology (77%), endocrinology (71.6%). Among those high risk pa- tients of osteoporosis, 171 cases ( 14.4% ) were taken bone mineral density examine with dual-energy X-ray absorptiome- try. The department of geriatrics had the highest testing rate (29. 8% ), followed by departments of rehabilitation (28.9%) and endocrinology (28.6%). There were 584 (49. 2% ) inpatients taking calcium themselves, but only 7.4% (43/584) of patients were treated rightly by osteoporotic medication in whom wished to be treated. Departments of endocrinology, rehabilitation and rheumatology contributed to the top three places among patients who were prescribed the anti-osteoporotic agents, with 12. 7%, 8.9%, and 8. 8% respectively. Conclusion The proportion of patients who are at risk for osteoporosis is very high among a large general hospital inpatients, however, the rates of diagnosis and treatment are very low. The majority are using calcium by themselves. These findings indicate that there is a great need to develop strategies to improve the current medical treatment service.
出处 《中华骨质疏松和骨矿盐疾病杂志》 2010年第1期43-48,共6页 Chinese Journal Of Osteoporosis And Bone Mineral Research
关键词 骨质疏松症 诊断 筛查 osteoporosis diagnosis treatment investigation
  • 相关文献

参考文献2

二级参考文献15

  • 1NOF. Clinician's guide to prevention and treatment of osteoporosis. http ://www. nof. org. 被引量:1
  • 2Osteoporosls: Review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis introduction. Osteoporos Int, 1998, 8 (Suppl 4) :S7-S80. 被引量:1
  • 3Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendrenate in women with osteoporesis: the fracture intervention trial. J Clin Endocrinol Metab, 2000, 85:4118-4124. 被引量:1
  • 4Chesnut III CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporetic fractures study. Am J Med, 2000, 109:267-276. 被引量:1
  • 5Cummings SR, Black DM, Thompson DE, et al. Effects of alendronate on risk of fracture in women with low Bone density but without vertebral fractures : results from the fracture intervention trial.JAMA, 1998, 280(24) :2077-2082. 被引量:1
  • 6Cummings SR, Bates D, Black DM. Clinical use of bone densitometry. JAMA, 2002, 288(15): 1889-1897. 被引量:1
  • 7Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporesis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA, 1999, 282 (7):637-645. 被引量:1
  • 8Harris ST, Watts NB, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal Osteoporosis. A randomized controlled trial. JAMA, 1999, 282(14) : 1344-1352. 被引量:1
  • 9McClung M, Geusens P, Miller P, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med, 2001, 344: 333-340. 被引量:1
  • 10Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev, 2002, 23 : 495-551. 被引量:1

共引文献78

同被引文献123

引证文献15

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部